What is Nkarta, Inc.'s earnings per share (EPS)?

Nkarta, Inc. (NKTX) reported diluted earnings per share of -$1.41 for fiscal year 2025. This represents a 11.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Nkarta, Inc. (NKTX) Financials

NKTX

FY2025 annual

Revenue $0 YoY not available

Net Income -$104.1M +4.3% YoY

EPS (Diluted) -$1.41 +11.9% YoY

Free Cash Flow -$89.9M +13.6% YoY

Market Cap $208.4M as of Sep 12, 2026

Price / Sales n/m revenue is not positive, FY2025

Price / Earnings n/m net loss, so no earnings multiple, FY2025

Price / Book 0.8x on $247.7M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 10, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NKTX SEC filings page.

Nkarta, Inc. (NKTX) reported $0 in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NKTX FY2025 2026-08-30

Nkarta’s dominant mechanic is recurring R&D-led cash consumption, supported by equity financing rather than debt.

From FY2023 to FY2025, R&D spending eased from $96.8M to $90.4M, yet operating cash outflow stayed near $86.2M to $88.7M. In FY2025, free cash flow nearly matched operating cash flow as capital expenditures fell to $1.2M, indicating that cash consumption is now primarily the operating development model rather than major facility investment.

The balance sheet is lightly debt-funded: FY2025 liabilities were $91.9M against $312.3M of equity, producing a debt-to-equity ratio of 0.3x. A reported liquidity comparison of 39.6 months of annual operating outflow further points to financing pressure being more tied to continued capital access than creditor claims.

Equity financing supplied $226.1M in FY2024 but only $141K in FY2025. With assets falling from $501.2M to $404.2M, the later balance-sheet movement indicates previously raised capital was being consumed rather than replenished through new financing.

Financial Health Signals

Financial health score not available

Nkarta, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-1.11

Nkarta, Inc. scores -1.11, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($208.4M) relative to total liabilities ($91.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

1/7

Nkarta, Inc. passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

Nkarta, Inc. reported a net loss of $104.1M while operations used $88.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA

-$40.4M

YoY-62.5%

QoQ-41.5%

Nkarta, Inc.'s EBITDA was -$40.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 62.5% from the same quarter a year earlier. Against the prior quarter it is down 41.5%.

Net Income

-$40.4M

YoY-75.7%

QoQ-45.0%

Nkarta, Inc. reported -$40.4M in net income in Q2 2026. This represents a decrease of 75.7% from the same quarter a year earlier. Against the prior quarter it is down 45.0%.

EPS (Diluted)

-$0.54

YoY-74.2%

QoQ-45.9%

Nkarta, Inc. earned -$0.54 per diluted share (EPS) in Q2 2026. This represents a decrease of 74.2% from the same quarter a year earlier. Against the prior quarter it is down 45.9%.

Revenue

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

-$24.4M

YoY-29.2%

QoQ+14.7%

Nkarta, Inc. recorded an outflow of $24.4M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 29.2% from the same quarter a year earlier. Against the prior quarter it is up 14.7%.

Cash & Debt

$25.0M

YoY-53.3%

QoQ-8.8%

5Y CAGR+0.4%

Nkarta, Inc. held $25.0M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

72M

YoY+0.8%

QoQ+0.1%

5Y CAGR+16.8%

Nkarta, Inc. had 72M shares outstanding in Q2 2026. This represents an increase of 0.8% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Return on Equity

-16.3%

YoY-9.9pp

QoQ-6.5pp

Nkarta, Inc.'s ROE was -16.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 9.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.5 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Net Margin

Not reported for Q2 2026.

Capital Allocation

R&D Spending

$29.0M

YoY+39.8%

QoQ+16.2%

Nkarta, Inc. invested $29.0M in research and development in Q2 2026. This represents an increase of 39.8% from the same quarter a year earlier. Against the prior quarter it is up 16.2%.

Capital Expenditures

$183K

YoY+32.6%

QoQ-55.7%

5Y CAGR-33.2%

Nkarta, Inc. invested $183K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 32.6% from the same quarter a year earlier. Against the prior quarter it is down 55.7%.

Share Buybacks

Not reported for Q2 2026.

NKTX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NKTX quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K
Revenue	N/A	$0	$0	N/A	N/A	N/A	N/A	$115K
R&D Expenses	N/A	$90.4M-6.5%	$96.7M0.0%	$96.8M+6.5%	$90.9M+43.3%	$63.4M+75.1%	$36.2M+110.4%	$17.2M
SG&A Expenses	N/A	$31.6M+0.4%	$31.4M-9.8%	$34.9M+24.3%	$28.1M+21.9%	$23.0M+50.6%	$15.3M+191.4%	$5.2M
Operating Income	N/A	-$122.0M+4.8%	-$128.2M+2.6%	-$131.7M-10.7%	-$119.0M-37.6%	-$86.4M-67.8%	-$51.5M-130.5%	-$22.3M
EBITDA	N/A	-$112.8M+5.2%	-$119.0M+5.4%	-$125.8M-8.1%	-$116.4M-37.5%	-$84.6M-66.9%	-$50.7M-131.0%	-$21.9M
Income Tax	N/A	$0	$0	$0	$0	$0	$0	$0
Net Income	N/A	-$104.1M+4.3%	-$108.8M+7.4%	-$117.5M-3.2%	-$113.8M-32.3%	-$86.1M+5.8%	-$91.4M-333.5%	-$21.1M
EPS (Basic)	N/A	-$1.41+11.9%	-$1.60+33.3%	-$2.40+8.0%	-$2.61+0.4%	-$2.62	N/A	N/A
EPS (Diluted)	-$1.57	-$1.41+11.9%	-$1.60+33.3%	-$2.40+8.0%	-$2.61+0.4%	-$2.62	N/A	N/A
Diluted Shares (Avg)	N/A	74M+9.0%	68M+38.5%	49M+12.3%	44M+32.8%	33M	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
R&D Expenses	$29.0M+39.8%	$25.0M+3.4%	N/A	$20.2M-20.0%	$20.8M-10.2%	$24.2M-4.2%	N/A	$25.3M+13.8%
SG&A Expenses	$14.1M+119.8%	$5.9M-52.5%	N/A	$7.1M-17.0%	$6.4M-15.5%	$12.4M+64.7%	N/A	$8.5M+20.3%
Operating Income	-$43.1M-58.6%	-$30.9M+15.6%	N/A	-$27.3M+19.3%	-$27.2M+11.5%	-$36.6M-11.6%	N/A	-$33.8M-15.4%
EBITDA	-$40.4M-62.5%	-$28.6M+16.6%	N/A	-$25.0M+20.4%	-$24.9M+12.4%	-$34.3M-12.5%	N/A	-$31.4M-15.0%
Income Tax	N/A	$0	N/A	$0	$0	$0	N/A	$0
Net Income	-$40.4M-75.7%	-$27.8M+13.0%	N/A	-$21.7M+23.4%	-$23.0M+8.1%	-$32.0M-8.4%	N/A	-$28.3M-10.5%
EPS (Basic)	-$0.54-74.2%	-$0.37+14.0%	-$0.37-8.8%	-$0.29+25.6%	-$0.31+8.8%	-$0.43+25.9%	-$0.34+40.4%	-$0.39+25.0%
EPS (Diluted)	-$0.54-74.2%	-$0.37+14.0%	-$0.37-8.8%	-$0.29+25.6%	-$0.31+8.8%	-$0.43+25.9%	-$0.34+40.4%	-$0.39+25.0%
Diluted Shares (Avg)	74M+0.7%	74M+0.5%	N/A	74M+0.6%	74M+0.7%	74M+45.8%	N/A	74M+49.9%

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Interest Expense.

NKTX Balance Sheet

NKTX quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K
Total Assets	$404.2M-19.4%	$501.2M+32.3%	$378.9M-19.9%	$472.9M+72.7%	$273.9M-18.9%	$337.6M+597.5%	$48.4M
Current Assets	$282.5M+3.4%	$273.3M+8.0%	$253.1M-29.8%	$360.7M+46.8%	$245.8M-22.9%	$318.8M+751.0%	$37.5M
Cash & Equivalents	$39.6M+42.2%	$27.9M-10.2%	$31.0M-17.2%	$37.5M-38.3%	$60.8M-37.1%	$96.7M+369.2%	$20.6M
Short-Term Investments	$236.6M-1.2%	$239.5M+10.3%	$217.1M-31.0%	$314.6M+77.5%	$177.3M-18.8%	$218.2M+1231.9%	$16.4M
Long-Term Investments	$16.1M-85.4%	$110.4M	$0	$0	$0	$0	$0
Total Liabilities	$91.9M-1.4%	$93.2M-11.7%	$105.6M+4.8%	$100.7M+339.2%	$22.9M+39.6%	$16.4M-77.8%	$73.9M
Current Liabilities	$22.3M+17.7%	$18.9M-18.9%	$23.3M+5.8%	$22.0M+70.3%	$12.9M+46.6%	$8.8M+8.2%	$8.2M
Non-Current Liabilities	$69.6M-6.3%	$74.3M-9.7%	$82.3M+4.6%	$78.7M+687.4%	$10.0M+31.5%	$7.6M-88.4%	$65.7M
Total Equity	$312.3M-23.4%	$408.0M+49.3%	$273.3M-26.6%	$372.2M+48.3%	$251.0M-21.9%	$321.2M+1360.6%	-$25.5M
Retained Earnings	-$648.3M-19.1%	-$544.2M-25.0%	-$435.4M-37.0%	-$317.9M-55.8%	-$204.1M-72.9%	-$118.0M-342.7%	-$26.7M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$337.6M-24.7%	$372.1M-20.9%	$404.2M-19.4%	$427.2M-19.7%	$448.3M-19.1%	$470.6M-18.4%	$501.2M+32.3%	$532.0M+31.1%
Current Assets	$188.0M-36.6%	$235.9M-13.1%	$282.5M+3.4%	$289.3M-0.3%	$296.6M-10.6%	$271.6M-38.7%	$273.3M+8.0%	$290.1M+3.2%
Cash & Equivalents	$25.0M-53.3%	$27.4M-48.0%	$39.6M+42.2%	$60.1M+5.5%	$53.4M-55.6%	$52.6M-79.0%	$27.9M-10.2%	$57.0M+48.9%
Short-Term Investments	$157.8M-33.2%	$203.1M-4.6%	$236.6M-1.2%	$222.2M-1.7%	$236.3M+15.6%	$212.9M+13.8%	$239.5M+10.3%	$226.1M-4.7%
Long-Term Investments	$57.7M+38.6%	$33.6M-59.9%	$16.1M-85.4%	$31.4M-73.7%	$41.6M-58.0%	$83.7M+752.4%	$110.4M	$119.5M
Total Liabilities	$89.9M-0.8%	$86.2M-6.1%	$91.9M-1.4%	$89.3M-11.7%	$90.6M-10.2%	$91.8M-11.1%	$93.2M-11.7%	$101.2M-7.2%
Current Liabilities	$23.6M+24.5%	$18.2M-2.9%	$22.3M+17.7%	$19.0M-15.5%	$18.9M-9.3%	$18.8M-15.5%	$18.9M-18.9%	$22.5M-12.4%
Non-Current Liabilities	$66.3M-7.5%	$68.0M-6.9%	$69.6M-6.3%	$70.3M-10.6%	$71.7M-10.4%	$73.0M-9.9%	$74.3M-9.7%	$78.7M-5.7%
Total Equity	$247.7M-30.7%	$285.9M-24.5%	$312.3M-23.4%	$337.9M-21.6%	$357.7M-21.1%	$378.8M-20.0%	$408.0M+49.3%	$430.9M+45.2%
Retained Earnings	-$716.5M-19.6%	-$676.1M-17.3%	-$648.3M-19.1%	-$620.9M-19.8%	-$599.2M-22.3%	-$576.2M-23.9%	-$544.2M-25.0%	-$518.3M-27.1%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

NKTX Cash Flow Statement

NKTX quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K
Operating Cash Flow	-$92.8M	-$88.7M+11.0%	-$99.7M-15.7%	-$86.2M-51.2%	-$57.0M+16.1%	-$67.9M-56.1%	-$43.5M-136.9%	-$18.4M
Depreciation & Amortization	N/A	$9.2M0.0%	$9.2M+55.9%	$5.9M+126.9%	$2.6M+44.4%	$1.8M+125.0%	$800K+100.0%	$400K
Stock-Based Compensation	N/A	$8.6M-48.8%	$16.7M-2.7%	$17.2M+2.0%	$16.9M+16.6%	$14.5M+114.3%	$6.7M+612.6%	$947K
Capital Expenditures	$1.1M	$1.2M-72.6%	$4.4M-84.3%	$28.1M-40.3%	$47.1M+837.5%	$5.0M-33.1%	$7.5M+289.6%	$1.9M
Free Cash Flow	-$93.9M	-$89.9M+13.6%	-$104.1M+8.9%	-$114.3M-9.8%	-$104.1M-42.7%	-$73.0M-43.0%	-$51.0M-151.4%	-$20.3M
Investing Cash Flow	$63.6M	$100.3M+177.4%	-$129.6M-264.0%	$79.0M+142.8%	-$184.7M-667.7%	$32.5M+115.5%	-$210.1M-1048.3%	-$18.3M
Financing Cash Flow	$746K	$141K-99.9%	$226.1M+32618.4%	$691K-99.7%	$219.0M+18120.6%	$1.2M-99.6%	$329.8M+565.2%	$49.6M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$24.2M-29.2%	-$28.2M+4.8%	-$21.6M+12.5%	-$18.7M+23.9%	-$18.8M+14.3%	-$29.6M-3.9%	-$24.8M-6.0%	-$24.5M-21.1%
Depreciation & Amortization	$2.7M+17.4%	$2.3M0.0%	$2.3M0.0%	$2.3M-4.2%	$2.3M0.0%	$2.3M0.0%	$2.3M0.0%	$2.4M+20.0%
Stock-Based Compensation	$1.9M-9.2%	$1.9M-33.0%	N/A	$1.8M-56.3%	$2.1M-53.5%	$2.8M-35.1%	N/A	$4.1M-5.5%
Capital Expenditures	$183K+32.6%	$413K-20.3%	$560K-49.2%	-$8K-99.0%	$138K-94.1%	$518K+196.0%	$1.1M-83.8%	$777K-87.4%
Free Cash Flow	-$24.4M-29.2%	-$28.6M+5.0%	-$22.2M+14.1%	-$18.7M+26.2%	-$18.9M+22.1%	-$30.1M-5.1%	-$25.9M+14.3%	-$25.3M+4.3%
Investing Cash Flow	$21.1M+8.5%	$15.9M-70.7%	$1.1M+124.4%	$25.4M+165.3%	$19.5M+118.1%	$54.3M+152.9%	-$4.5M-128.5%	-$38.9M-232.2%
Financing Cash Flow	$676K+777.9%	$6K	$64K-65.2%	$0-100.0%	$77K+120.9%	$0-100.0%	$184K-37.6%	$2K

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

NKTX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NKTX quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	-19433.9%
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	-18327.0%
Return on Equity	-33.3%-6.7pp	-26.7%+16.3pp	-43.0%-12.4pp	-30.6%+3.7pp	-34.3%-5.9pp	-28.4%	N/A
Return on Assets	-25.8%-4.0pp	-21.7%+9.3pp	-31.0%-6.9pp	-24.1%+7.4pp	-31.4%-4.4pp	-27.1%+16.5pp	-43.5%
Current Ratio	12.69-1.8x	14.45+3.6x	10.85-5.5x	16.36-2.6x	18.99-17.1x	36.10+31.5x	4.59
Debt-to-Equity	0.29+0.1x	0.23-0.2x	0.39+0.1x	0.27+0.2x	0.090.0x	0.05	N/A
Asset Turnover	0.000.0x	0.00	N/A	N/A	N/A	N/A	0.00
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	-17647.8%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Return on Equity	-16.3%-9.9pp	-9.7%-1.3pp	N/A	-6.4%+0.2pp	-6.4%-0.9pp	-8.4%-2.2pp	N/A	-6.6%+2.1pp
Return on Assets	-12.0%-6.8pp	-7.5%-0.7pp	N/A	-5.1%+0.3pp	-5.1%-0.6pp	-6.8%-1.7pp	N/A	-5.3%+1.0pp
Current Ratio	7.98-7.7x	12.96-1.5x	12.69-1.8x	15.23+2.3x	15.67-0.2x	14.48-5.5x	14.45+3.6x	12.91+1.9x
Debt-to-Equity	0.36+0.1x	0.30+0.1x	0.29+0.1x	0.260.0x	0.250.0x	0.240.0x	0.23-0.2x	0.23-0.1x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Nkarta, Inc. NKTX	FY2025	$0	-$104.1M	N/A	$208.4M	—
Agenus Inc. AGEN	FY2025	$114.2M	-$3.1M	-2.7%	$312.4M	47/100
Genelux Corporation GNLX	FY2025	$8K	-$32.1M	N/A	$112.7M	—
Instil Bio, Inc. TIL	FY2025	N/A	-$71.4M	N/A	$50.1M	—
Coherus Oncology, Inc. CHRS	FY2025	$42.2M	$168.0M	N/A	$205.5M	60/100

Where Nkarta, Inc. Ranks

Frequently Asked Questions

What is Nkarta, Inc.'s annual revenue?

Nkarta, Inc. (NKTX) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is Nkarta, Inc. profitable?

No, Nkarta, Inc. (NKTX) reported a net income of -$104.1M in fiscal year 2025.

What is Nkarta, Inc.'s EBITDA?

Nkarta, Inc. (NKTX) had EBITDA of -$112.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Nkarta, Inc.'s return on equity (ROE)?

Nkarta, Inc. (NKTX) has a return on equity of -33.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Nkarta, Inc.'s free cash flow?

Nkarta, Inc. (NKTX) recorded an outflow of $89.9M in free cash flow during fiscal year 2025. This represents a 13.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Nkarta, Inc.'s operating cash flow?

Nkarta, Inc. (NKTX) recorded an outflow of $88.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Nkarta, Inc.'s total assets?

Nkarta, Inc. (NKTX) had $404.2M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Nkarta, Inc.'s capital expenditures?

Nkarta, Inc. (NKTX) invested $1.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Nkarta, Inc. spend on research and development?

Nkarta, Inc. (NKTX) invested $90.4M in research and development during fiscal year 2025.

How many shares does Nkarta, Inc. have outstanding?

Nkarta, Inc. (NKTX) had 71M shares outstanding as of fiscal year 2025.

What is Nkarta, Inc.'s current ratio?

Nkarta, Inc. (NKTX) had a current ratio of 12.69 as of fiscal year 2025, which is generally considered healthy.

What is Nkarta, Inc.'s debt-to-equity ratio?

Nkarta, Inc. (NKTX) had a debt-to-equity ratio of 0.29 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Nkarta, Inc.'s return on assets (ROA)?

Nkarta, Inc. (NKTX) had a return on assets of -25.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Nkarta, Inc.'s P/E ratio?

Nkarta, Inc. (NKTX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $208.4M as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Nkarta, Inc.'s price-to-sales ratio?

Nkarta, Inc. (NKTX) has no price-to-sales ratio at the moment: revenue is not positive (FY2025). The market capitalization is $208.4M as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does Nkarta, Inc.'s liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Nkarta, Inc. (NKTX) held $292.4M in cash, cash equivalents and investments, and reported an operating cash outflow of $88.7M over that year. Dividing the one by the other, the reported balance equals about 40 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Nkarta, Inc.'s Altman Z-Score?

Nkarta, Inc. (NKTX) has an Altman Z-Score of -1.11, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Nkarta, Inc.'s Piotroski F-Score?

Nkarta, Inc. (NKTX) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Nkarta, Inc.'s earnings high quality?

Nkarta, Inc. (NKTX) reported a net loss of $104.1M while operations used $88.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.